Controindicazioni ed effetti collaterali
Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce body weight, glycaemia, blood pressure, postprandial lipaemia and infammation actions that could contribute to the reduction of cardiovascular events
Here are the factors we evaluate during your consultation: Medical history including diabetes, thyroid conditions, GI history, and current medications Weight loss goals: do you prefer steady progress or do you want a stronger, faster reduction
This includes people with a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)
L-Carnitine may enhance antioxidant capacity, rescuing inflammation and increasing nitric oxide levels (Damianou, A